41 – 50 of 115
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY : Lessons From a 5-Year Pediatric Swedish National Cohort Study
(
- Contribution to journal › Article
-
Mark
Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
(
- Contribution to journal › Article
- 2019
-
Mark
Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4 and 5 Include Potentially "Causal Residues" Responsible for the Risk of Childhood Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article
-
Mark
Screening for asymptomatic β-cell autoimmunity in young children
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children
(
- Contribution to journal › Article
-
Mark
Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform : relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Effect of screening for type 1 diabetes on early metabolic control : the DiPiS study
(
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Who is enrolling? The path to monitoring in type 1 diabetes trialnet’s pathway to prevention
(
- Contribution to journal › Article